BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6697538)

  • 1. Revised recommendation (1983) on evaluation of diagnostic kits. Part 1. Recommendations for specifications on labelling of clinical laboratory materials. International Federation of Clinical Chemistry.
    Logan JE
    Clin Chim Acta; 1984 Mar; 137(3):371F-379F. PubMed ID: 6697538
    [No Abstract]   [Full Text] [Related]  

  • 2. Revised recommendation (1983) on evaluation of diagnostic kits. Part 1. Recommendations for specifications on labelling of clinical laboratory materials.
    Logan JE
    J Clin Chem Clin Biochem; 1983 Dec; 21(12):893-8. PubMed ID: 6663249
    [No Abstract]   [Full Text] [Related]  

  • 3. Revised recommendation (1983) on evaluation of diagnostic kits. Part 2. Guidelines for the evaluation of clinical chemistry kits. International Federation of Clinical Chemistry.
    Logan JE
    Clin Chim Acta; 1984 Mar; 137(3):381F-386F. PubMed ID: 6697539
    [No Abstract]   [Full Text] [Related]  

  • 4. Revised recommendation (1983) on evaluation of diagnostic kits. Part 2. Guidelines for the evaluation of clinical chemistry kits.
    Logan JE
    J Clin Chem Clin Biochem; 1983 Dec; 21(12):899-902. PubMed ID: 6663250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provisional recommendation (1978) on evaluation of diagnostic kits. Part 1. Recommendation for specifications of labelling of clinical laboratory materials (Stage 2, Draft 1).
    Rubin M; Barnett RN; Bayse D; Beutler E; Brown SS; Logan JE; Reimer CB; Westgard JO; Wilding P
    Clin Chem; 1979 Aug; 25(8):1499-502. PubMed ID: 455693
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of package inserts for diagnostic kits.
    Secchiero S; Sciacovelli L; Bonvicini P; Zaninotto M; Plebani M
    Clin Chem Lab Med; 1999 Jun; 37(6):663-5. PubMed ID: 10475075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labelling deficiencies in test kits for the detection of antibodies to rubella.
    Katz L; Hinberg IH; Weber F
    Clin Biochem; 1979 Aug; 12(4):146. PubMed ID: 487565
    [No Abstract]   [Full Text] [Related]  

  • 8. Coping with the IVD directive.
    Gower G
    Med Device Technol; 2000 Oct; 11(8):28-9. PubMed ID: 11185185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Federation of Clinical Chemistry, Scientific Committee, Analytical Section: evaluation of performance of diagnostic reagent sets used in health laboratories with limited resources. Appendix A: Glucose.
    Logan JE; Bayse DD; Koedam JC; Mather A; Wilding P
    J Clin Chem Clin Biochem; 1984 Nov; 22(11):827-44. PubMed ID: 6527100
    [No Abstract]   [Full Text] [Related]  

  • 10. International Federation of Clinical Chemistry (IFCC). Scientific Committee, Analytical Section. IFCC/WHO principles and recommendations on evaluation of diagnostic reagent sets used in health laboratories with limited resources. Part 3. Selection and evaluation using reference materials. General considerations.
    Logan JE; Bayse DD; Koedam JC; Mather A; Wilding P
    J Clin Chem Clin Biochem; 1984 Aug; 22(8):573-82. PubMed ID: 6491619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expiry-date tampering.
    Watt G
    Lancet; 2004 Jan; 363(9403):172. PubMed ID: 14726190
    [No Abstract]   [Full Text] [Related]  

  • 12. International Federation of Clinical Chemistry, Scientific Committee, Analytical Section: IFCC/WHO principles and recommendations on evaluation of diagnostic reagent sets used in health laboratories with limited resources. Part 4. Evaluation of performance using reference materials of analytes commonly determined in blood serum or plasma.
    Logan JE; Bayse DD; Koedam JC; Mather A; Wilding P
    J Clin Chem Clin Biochem; 1984 Nov; 22(11):817-26. PubMed ID: 6527099
    [No Abstract]   [Full Text] [Related]  

  • 13. Expiry-date tampering.
    Day JN; Hien TT; Farrar J
    Lancet; 2004 Jan; 363(9403):172. PubMed ID: 14726189
    [No Abstract]   [Full Text] [Related]  

  • 14. Provisional recommendation (1978) on evaluation of diagnostic kits. Part 2. Guidelines for the evaluation of clinical chemistry kits (Stage 2, Draft1).
    Rubin M; Barnett RN; Bayse D; Beutler E; Brown SS; Logan JE; Reimer CB; Westgard JO; Wilding P
    Clin Chem; 1979 Aug; 25(8):1503-5. PubMed ID: 455694
    [No Abstract]   [Full Text] [Related]  

  • 15. A recommended scheme for the evaluation of kits in the clinical laboratory.
    Percy-Robb IW; Broughton PM; Jennings RD; McCormack JJ; Neill DW; Saunders RA; Warner M
    Ann Clin Biochem; 1980 Sep; 17(5):217-26. PubMed ID: 7447355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Diagnostic Tests for Neglected Infectious Diseases: Case Study Highlights Need for Customer Awareness and Postmarket Surveillance.
    Barbé B; Verdonck K; El-Safi S; Khanal B; Teav S; Lilo Kalo JR; Ravinetto R; Chappuis F; Boelaert M; Jacobs J
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0004655. PubMed ID: 27812099
    [No Abstract]   [Full Text] [Related]  

  • 17. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists.
    Dati F; Schumann G; Thomas L; Aguzzi F; Baudner S; Bienvenu J; Blaabjerg O; Blirup-Jensen S; Carlström A; Petersen PH; Johnson AM; Milford-Ward A; Ritchie RF; Svendsen PJ; Whicher J
    Eur J Clin Chem Clin Biochem; 1996 Jun; 34(6):517-20. PubMed ID: 8831057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guiding principles and recommendations on labelling of clinical laboratory materials: a WHO memorandum.
    Bull World Health Organ; 1978; 56(6):881-5. PubMed ID: 310730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A scheme for the evaluation of methods in clinical chemistry with particular application to those measuring enzyme activities. Part I: general considerations.
    Kim EK; Logan JE
    Clin Biochem; 1978 Dec; 11(6):238-43. PubMed ID: 737848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for description of immunoassay kits.
    Aakvaag A; Leskinen E; Lindstedt G; Möller J; Nyberg A; Weber T
    Scand J Clin Lab Invest; 1990 Feb; 50(1):95-8. PubMed ID: 2315649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.